Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether zolendronic acid, a third generation bisphosphonate, is effective in preventing bone loss in the first year after kidney transplantation.


Clinical Trial Description

For the treatment of osteoporosis in the general population, a number of drugs reduce BMD (bone mineral density) loss and the rate of incident fractures. For instance, bisphosphonates improve BMD, reduce hip fracture rates and decrease mortality in post-menopausal women. Because of lack of data on safety and an increased risk of adverse effects, the use of these drugs is controversial in patients with chronic kidney disease (CKD) and abnormalities of PTH or vitamin D, an estimated glomerular filtration rate (GFR) less than 30 ml/min/1.73m² (CKD stages 4 and 5) and after transplantation. The efficacy of short and long term bisphosphonate treatment after kidney transplantation has been examined; however, histomorphometric and fracture rate reduction data are lacking.

The purpose of this study is to determine whether zolendronic acid, a third generation bisphosphonate, is effective in preventing bone loss in the first year after kidney transplantation. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01675089
Study type Interventional
Source University of Sao Paulo General Hospital
Contact
Status Completed
Phase Phase 4
Start date July 2012
Completion date May 2014

See also
  Status Clinical Trial Phase
Completed NCT03960437 - The Effect of Etelcalcetide on CKD-MBD Phase 2
Recruiting NCT03716128 - Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function
Recruiting NCT02147782 - Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
Completed NCT00108394 - Osteopenia and Renal Osteodystrophy: Evaluation and Management Phase 4
Completed NCT00527085 - 12-month Study of AMG 073 in Renal Osteodystrophy Phase 2
Completed NCT00560300 - Regulation of Bone Formation in Renal Osteodystrophy Phase 2
Active, not recruiting NCT00752401 - Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients Phase 3
Completed NCT00364234 - Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD N/A
Completed NCT00859612 - Renal Osteodystrophy: A Fresh Approach N/A
Completed NCT00004340 - Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis Phase 2
Not yet recruiting NCT01382966 - Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients N/A
Completed NCT03626246 - Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
Terminated NCT00374712 - Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia N/A
Terminated NCT03960554 - The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients Phase 2
Recruiting NCT02556216 - Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) N/A
Recruiting NCT05880914 - Precision Medicine Approaches to Renal Osteodystrophy Early Phase 1
Withdrawn NCT01665651 - Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy Phase 2